clinical laboratory test

Tag: clinical laboratory test

Monitoring Patients on Opioids Is Opportunity for Clinical Labs

By Joseph Burns, from the Volume XXVI No. 13 – September 23, 2019 issue

CEO SUMMARY: When developing a program to identify and treat patients who misused opioids or needed chronic opioid therapy, Community Health Network (CHN) of Indianapolis recognized that clinical lab toxicology tests were one of the few sources of objective data about patient compliance. When CHN developed its Chronic Opioid Therapy (COT) program, protocols were included that

View Article

Monitoring Patients on Opioids with Toxicology Screens Is Opportunity for Clinical Labs

By Mary Van Doren, from the Volume XXVI No. 13 – September 23, 2019 issue

This is an excerpt of a 2,883-word article in the Sept. 23, 2019 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group.
CEO SUMMARY: In this first industry briefing on such a program, THE DARK REPORT explains that Community Health Network (CHN) of Indianapolis recognized that clinical

View Article

Iowa Nursing Homes Lose Phlebotomy Service Twice

By Joseph Burns, from the Volume XXVI No. 8 – June 10, 2019 issue

CEO SUMMARY: It may be without precedent in the clinical lab industry that a laid-off lab manager launches a nonprofit mobile phlebotomy service in order to continue services to homebound patients, nursing homes, and long-term care facilities. The events in the Quad Cities of Moline, Ill. and Davenport, Iowa, are also the most recent example

View Article

May 20, 2019 Intelligence: Late Breaking Lab News

By Robert Michel, from the Volume XXVI No. 7 – May 20, 2019 issue

Canada faces a similar shortage of medical technologists (MTs) as exists in the United States. “We have reached the point now where some laboratories have been closed for weeks due to insufficient staffing, which is a cascading problem for patients and the healthcare system,” stated Maria Klement, President of the Canadian Society for Medical Laboratory

View Article

Fla. Blue Cross Contract May Be Next Battleground

By Joseph Burns, from the Volume XXVI No. 4 – March 18, 2019 issue

CEO SUMMARY: In Florida, the Blue Cross Blue Shield contract is coming up for renewal and the question is whether it will renew as exclusive to one national lab company. But Florida is not the only state where BCBS plans are planning to issue new contracts. Among the Blues plans that may ask for proposals

View Article

Is There a Future for Hospital Lab Outreach Programs?

By Mary Van Doren, from the Volume XXVI No. 1 – January 14, 2019 issue

CEO SUMMARY: This will be one of the most challenging years facing the clinical lab industry since the early 1990s. The CMS scheme to collect private payer lab test prices and use that data to set Medicare clinical laboratory test prices is proving to be an indiscriminate tool that is poised to undermine the financial integrity of many labs,

View Article

Why PAMA May Be Poised to Disrupt Lab Industry

By Robert Michel, from the Volume XXVI No. 1 – January 14, 2019 issue

CEO SUMMARY: This will be one of the most challenging years facing the clinical lab industry since the early 1990s, when closed panel HMOs were the disruptive force that generated deep cuts in lab test prices. However, unlike HMOs of that era, the CMS scheme to collect private payer lab test prices and use that

View Article

Several Big Surprises in 2018’s Top 10 Lab Stories

By Robert Michel, from the Volume XXV No. 18 – December 24, 2018 issue

CEO SUMMARY: This year’s list of the Top 10 Lab Industry Stories for 2018 is dominated by new directives from Medicare and private health insurers, as well as significant decisions by federal courts. Collectively, these developments create new compliance risks for all clinical laboratories and anatomic pathology groups. What is more notable about these top

View Article

Québec’s Laboratory Consolidation Plan Aims to Save $13.5M

By Joseph Burns, from the Volume XXV No. 11 – July 30, 2018 issue

CEO SUMMARY: In the Province of Québec, an ambitious project is under-way to consolidate the clinical laboratory testing of 123 laboratories into 11 centralized lab clusters. It is one of the largest lab consolidation projects nowhappening in the world. Among the goals of this project is to improve qualityand efficiency while incurring no additional costs.

View Article

How Many Patients Were Harmed at Theranos?

By Joseph Burns, from the Volume XXV No. 8 – May 29, 2018 issue

CEO SUMMARY: Reporting in The Wall Street Journal shows that some physicians in Arizona were concerned about the harm from erroneous test results from Theranos Inc. But those physicians who expressed concern may have been only a small set of the number of physicians who were worried about patient harm. After reviewing the concerns about

View Article

Tag: clinical laboratory test

Enter Your Login Credentials